CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating activities:
Net income	$ 69,737	$ 88,905
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	105,597	91,218
Accretion of debt premium and discount, net	(695)	(728)
Deferred financing cost amortization	1,766	1,796
Accretion of above- and below-market leases, net	(3,276)	(2,408)
Tenant inducement amortization and other	750	731
Gain on sale of real estate assets	(3,070)	(15,142)
Equity based compensation	4,113	3,359
Changes in operating assets and liabilities:
Receivables, net	9,442	28,639
Deferred charges and prepaid expenses	(7,140)	(9,020)
Other assets	49	(1,222)
Accounts payable, accrued expenses and other liabilities	(47,185)	(57,612)
Net cash provided by operating activities	130,088	128,516
Investing activities:
Improvements to and investments in real estate assets	(82,509)	(76,861)
Acquisitions of real estate assets	(3,144)	0
Proceeds from sales of real estate assets	21,636	67,237
Purchase of marketable securities	(4,477)	(4,366)
Proceeds from sale of marketable securities	5,035	4,811
Net cash used in investing activities	(63,459)	(9,179)
Financing activities:
Repayment of borrowings under unsecured revolving credit facility	(407,000)	(98,500)
Proceeds from borrowings under unsecured revolving credit facility	407,000	80,000
Proceeds from unsecured notes and term loans	399,324	399,264
Repayment of borrowings under unsecured notes	(632,312)	0
Deferred financing and debt extinguishment costs	(3,718)	(3,766)
Net proceeds from issuances of common shares	(78)	0
Distributions to common stockholders	(89,465)	(83,866)
Repurchases of common shares in conjunction with equity award plans	(11,644)	(12,962)
Net cash provided by (used in) financing activities	(337,893)	280,170
Net change in cash, cash equivalents and restricted cash	(271,264)	399,507
Cash, cash equivalents and restricted cash at beginning of period	378,692	18,904
Cash, cash equivalents and restricted cash at end of period	107,428	418,411
Reconciliation to consolidated balance sheets:
Cash and cash equivalents	106,534	407,105
Restricted cash	894	11,306
Cash, cash equivalents and restricted cash at end of period	107,428	418,411
Supplemental disclosure of cash flow information:
Cash paid for interest, net of amount capitalized of $1,264 and $920	73,213	49,384
Change in accrued capital expenditures	(3,396)	(454)
Brixmor Operating Partnership LP
Operating activities:
Net income	69,737	88,905
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	105,597	91,218
Accretion of debt premium and discount, net	(695)	(728)
Deferred financing cost amortization	1,766	1,796
Accretion of above- and below-market leases, net	(3,276)	(2,408)
Tenant inducement amortization and other	750	731
Gain on sale of real estate assets	(3,070)	(15,142)
Equity based compensation	4,113	3,359
Changes in operating assets and liabilities:
Receivables, net	9,442	28,639
Deferred charges and prepaid expenses	(7,140)	(9,020)
Other assets	49	(1,222)
Accounts payable, accrued expenses and other liabilities	(47,185)	(57,612)
Net cash provided by operating activities	130,088	128,516
Investing activities:
Improvements to and investments in real estate assets	(82,509)	(76,861)
Acquisitions of real estate assets	(3,144)	0
Proceeds from sales of real estate assets	21,636	67,237
Purchase of marketable securities	(4,477)	(4,366)
Proceeds from sale of marketable securities	5,035	4,811
Net cash used in investing activities	(63,459)	(9,179)
Financing activities:
Repayment of borrowings under unsecured revolving credit facility	(407,000)	(98,500)
Proceeds from borrowings under unsecured revolving credit facility	407,000	80,000
Proceeds from unsecured notes and term loans	399,324	399,264
Repayment of borrowings under unsecured notes	(632,312)	0
Deferred financing and debt extinguishment costs	(3,718)	(3,766)
Net proceeds from issuances of common shares	(78)	0
Partner distributions and repurchases of OP Units	(101,533)	(97,423)
Net cash provided by (used in) financing activities	(338,317)	279,575
Net change in cash, cash equivalents and restricted cash	(271,688)	398,912
Cash, cash equivalents and restricted cash at beginning of period	378,032	18,904
Cash, cash equivalents and restricted cash at end of period	106,344	417,816
Reconciliation to consolidated balance sheets:
Cash and cash equivalents	105,450	406,510
Restricted cash	894	11,306
Cash, cash equivalents and restricted cash at end of period	106,344	417,816
Supplemental disclosure of cash flow information:
Cash paid for interest, net of amount capitalized of $1,264 and $920	73,213	49,384
Change in accrued capital expenditures	$ (3,396)	$ (454)